SCHEMBL2516416

SCHEMBL2516416

Cc1ncc(C)c(NN)n1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NUDT1 P36639 2/20 0.38
▸ KDM4E B2RXH2 3/20 0.35
▸ ALDH1A1 P00352 3/20 0.35
▸ MAPT P10636 2/20 0.35
▸ GAA P10253 1/20 0.35
▸ LMNA P02545 2/20 0.33
▸ NOS3 P29474 1/20 0.33
▸ NOS1 P29475 1/20 0.33
▸ NOS2 P35228 1/20 0.33
▸ AURKA O14965 1/20 0.33
▸ RAB9A P51151 2/20 0.31
▸ POLB P06746 1/20 0.31
▸ NPC1 O15118 1/20 0.31
▸ TP53 P04637 1/20 0.31
▸ MPO P05164 1/20 0.31
▸ CYP1A2 P05177 1/20 0.31
▸ CYP3A4 P08684 1/20 0.31
▸ CYP2D6 P10635 1/20 0.31
▸ PKM P14618 1/20 0.31
▸ GOT1 P17174 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18031996 0.80 IGF1R (0.34) KDM4EALDH1A1MAPTGAALMNA
SCHEMBL14230821 0.80 NUDT1 (0.58) NUDT1KDM4EALDH1A1MAPTGAA
SCHEMBL12586215 0.79 NUDT1 (0.35) NUDT1LMNANOS3NOS1NOS2
SCHEMBL24533739 0.78 NUDT1 (0.36) NUDT1KDM4EALDH1A1MAPTGAA
SCHEMBL27829647 0.78 SYK (0.36) ALDH1A1LMNAAURKASTK17ASYK
SCHEMBL4570565 0.76 NUDT1 (0.33) NUDT1AURKA
SCHEMBL17863608 0.75 ALDH1A1 (0.36) NUDT1KDM4EALDH1A1MAPTLMNA
SCHEMBL15537585 0.75 LMNA (0.41) KDM4EALDH1A1LMNANOS3NOS1
SCHEMBL8398333 0.72 GABRP (0.43) KDM4EALDH1A1MAPTGAALMNA
SCHEMBL12279163 0.71 RAPGEF4 (0.45) MAPTLMNAAURKARAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8034954-B2 Calcium channel antagonists ICAGEN, INC. (US) 2011-10-11 — — US claimed
CN-110831600-B Indole AHR inhibitors and uses thereof 医肯纳肿瘤学公司 2023-10-17 — — CN disclosed
EP-3753941-A1 PYRIMIDINE-FUSED CYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF Shanghai Blueray Biopharma Co., Ltd. (CN) 2020-12-23 — — EP disclosed
CN-110831600-A Indole AHR inhibitors and uses thereof 金恩医疗公司 2020-02-21 — — CN disclosed
WO-2019158019-A1 PYRIMIDINE-FUSED CYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF 上海青煜医药科技有限公司 2019-08-22 — — WO disclosed
EP-2629616-A2 SUBSTITUTED AMINO-TRIAZOLYL PDE10 INHIBITORS Merck Sharp & Dohme Corp. (US) 2013-08-28 — — EP disclosed
WO-2012054366-A2 SUBSTITUTED AMINO-TRIAZOLYL PDE10 INHIBITORS MERCK SHARP & DOHME CORP. (US) 2012-04-26 — — WO disclosed
Send feedback